Of particular interest, two independent studies using mouse melanoma tumor models demonstrated NK cell ability to recruit and promote the differentiation and/or survival of type 1 conventional dendritic cells (cDC1), a subset of professional antigen-presenting cells specialized in CD8+ T cell priming [7,8]. The gene discussed is CD8A; the disease is melanoma.